Can We Learn From Viruses How to Prevent Type 1 Diabetes?: The Role of Viral Infections in the Pathogenesis of Type 1 Diabetes and the Development of Novel Combination Therapies

Autor von Herrath, Matthias
Vydáno 2009

Immunotherapy After Recent-Onset Type 1 Diabetes: Combinatorial Treatment for Achieving Long-Term Remission in Humans?

Autor Bresson, Damien, von Herrath, Matthias
Vydáno 2004

Limitations in Immunotherapy with CD3 Antibodies: Comment on the Article by Drs. Chatenoud and Bach

Autor Bresson, Damien, von Herrath, Matthias
Vydáno 2005

How can we improve the translational landscape for a faster cure of type 1 diabetes?

Autor von Herrath, Matthias, Chan, Andrew
Vydáno 2009

Immunotherapy for the Prevention and Treatment of Type 1 Diabetes: Optimizing the path from bench to bedside

Autor Bresson, Damien, von Herrath, Matthias
Vydáno 2009

Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential

Autor Peakman, Mark, von Herrath, Matthias
Vydáno 2010

Protection against or triggering of Type 1 diabetes? Different roles for viral infections

Autor Boettler, Tobias, von Herrath, Matthias
Vydáno 2011

Humanizing Animal Models: A Key to Autoimmune Diabetes Treatment

Autor Bresson, Damien, von Herrath, Matthias
Vydáno 2011

IL-7 receptor α blockade, an off-switch for autoreactive T cells

Autor Boettler, Tobias, von Herrath, Matthias
Vydáno 2012

The shifting paradigm of a “Cure” for Type 1 Diabetes. Is technology replacing Immune based therapies?

Autor Pettus, Jeremy, Von Herrath, Matthias
Vydáno v Acta Diabetol (2017)

The Development of Immunotherapy Strategies for the Treatment of Type 1 Diabetes

Autor Coppieters, Ken, von Herrath, Matthias
Vydáno v Front Med (Lausanne) (2018)

Lost in translation: barriers to implementing clinical immunotherapeutics for autoimmunity

Autor von Herrath, Matthias G., Nepom, Gerald T.
Vydáno 2005

Immunosuppression in islet transplantation

Autor Van Belle, Tom, von Herrath, Matthias
Vydáno 2008

Histopathology of Type 1 Diabetes: Old Paradigms and New Insights

Autor Coppieters, Ken T., von Herrath, Matthias G.
Vydáno 2009

Metabolic syndrome – Removing roadblocks to therapy: Antigenic immunotherapies()

Autor Coppieters, Ken T., von Herrath, Matthias G.
Vydáno 2014

2011 Update: Antigen Specific Therapy in Type 1 Diabetes

Autor Michels, Aaron W., von Herrath, Matthias
Vydáno 2011

Do viral infections protect from or enhance type 1 diabetes and how can we tell the difference?

Autor Christen, Urs, von Herrath, Matthias G
Vydáno 2011

A Deeper Look into Type 1 Diabetes – Imaging Immune Responses during Onset of Disease

Autor Christoffersson, Gustaf, von Herrath, Matthias G.
Vydáno v Front Immunol (2016)

Motifs for a deadly encounter

Autor Coppieters, Ken T, von Herrath, Matthias G
Vydáno v Nat Immunol (2012)

Viruses and Cytotoxic T Lymphocytes in Type 1 Diabetes

Autor Coppieters, Ken T., von Herrath, Matthias G.
Vydáno v Clin Rev Allergy Immunol (2011)